Neonatal Bronchial Hyperresponsiveness Precedes Acute Severe Viral Bronchiolitis in Infants
Overview
Affiliations
Background: Respiratory syncytial virus and other respiratory tract viruses lead to common colds in most infants, whereas a minority develop acute severe bronchiolitis often requiring hospitalization. We hypothesized that such an excessive response to respiratory tract viral infection is caused by host factors reflected in pre-existing increased bronchial responsiveness.
Objective: We sought to compare bronchial responsiveness and lung function in 1-month-old neonates who later develop acute severe bronchiolitis with those who do not.
Methods: We measured infant lung function (n=402) and bronchial responsiveness to methacholine (n=363) using the raised-volume rapid thoracoabdominal compression technique before any respiratory symptoms in 1-month-old neonates from the Copenhagen Prospective Study of Asthma in Childhood birth cohort born to mothers with asthma. The children were prospectively monitored for respiratory symptoms and given a diagnosis of acute severe bronchiolitis according to a fixed algorithm.
Results: Thirty-four (8.5%) infants had acute severe bronchiolitis before 2 years of age, 21 (62%) were hospitalized, and 23 (67%) of the cases were associated with respiratory syncytial virus. Children who later had acute severe bronchiolitis irrespective of viral species had a 2.5-fold increased responsiveness to methacholine (provocative dose of methacholine producing a 15% decrease in transcutaneous oxygen pressure [PD(15)]) at age 1 month compared with control subjects (median PD(15) in cases vs control subjects, 0.13 vs 0.33 μmol; P=.01), whereas differences in baseline airflow were not significant for forced expiratory volume at 0.5 seconds (mean z score for cases vs control subjects, -0.18 vs -0.01; P=.36) and forced expiratory flow at 50% of forced vital capacity (mean z score for cases vs control subjects, -0.37 vs -0.09; P=.13).
Conclusion: Bronchial hyperresponsiveness in at-risk neonates precedes acute severe bronchiolitis in response to infections with respiratory tract virus.
Amram T, Duek O, Golan-Tripto I, Goldbart A, Greenberg D, Hazan G Pediatr Pulmonol. 2025; 60(1):e27474.
PMID: 39760467 PMC: 11748096. DOI: 10.1002/ppul.27474.
Gayoso-Liviac M, Nino G, Montgomery A, Hong X, Wang X, Gutierrez M Pediatr Pulmonol. 2023; 59(3):679-687.
PMID: 38153215 PMC: 10901459. DOI: 10.1002/ppul.26810.
Grandinetti R, Fainardi V, Caffarelli C, Capoferri G, Lazzara A, Tornesello M J Clin Med. 2022; 11(21).
PMID: 36362786 PMC: 9655250. DOI: 10.3390/jcm11216558.
The assessment of future RSV immunizations: How to protect all infants?.
Bont L, Olivier C, Herting E, Esposito S, Navarro Alonso J, Lega F Front Pediatr. 2022; 10:981741.
PMID: 36016878 PMC: 9396232. DOI: 10.3389/fped.2022.981741.
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?.
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M Front Immunol. 2022; 13:880368.
PMID: 35572550 PMC: 9096079. DOI: 10.3389/fimmu.2022.880368.